TOP STORIES

• REGULATORY Early Honebuto Draft Contains CEA Expansion, Ramp-Up of FIH Trial Sites
  June 4, 2025

• ORGANIZATION New JPMA Chief Calls for Clear-Cut Evaluation of Innovation in FY2026 Reform
  June 3, 2025

• REGULATORY New Skipper of PMDA’s Review Center Wears Multiple Hats to Push Fight against Drug Loss
  June 2, 2025

• BUSINESS Taking on Solid Tumors - 3: J&J to Soon Have 3 Bispecifics in Japan as Rybrevant Gathers Pace
  May 30, 2025

• BUSINESS Towa, Sawai Log Two-Digit Growth in Operating Profit, but Industry Sees Divide: Tally
  May 30, 2025

• BUSINESS Taking on Solid Tumors - 2: Chugai Poised to Break through Solid Cancer “Wall” with Trispecific Antibodies
  May 29, 2025

• REGULATORY LDP Pharma Study Group’s Final Proposal Urges Raising of Social Security Budget Ceiling
  May 29, 2025

• REGULATORY LDP Fiscal Reform HQ’s Proposal Keeps Budget Ceiling Intact, but Urges Action on Wage Front
  May 28, 2025

• REGULATORY MOF Panel Again Presses for Expansion of CEA Scheme: “Spring” Proposal
  May 27, 2025

• REGULATORY Honebuto Outline Includes “Raise in Official Prices,” but Details Yet Unknown
  May 27, 2025

• COMMENTARY Next Wave of ALS Drugs Emerging as Novartis, Nipro Enter Development Fray
  May 27, 2025

• BUSINESS Sun Pharma Japan Eyes 10%-Plus CAGR as It Pivots to New Drug Biz
  May 26, 2025

• BUSINESS Novartis Keen to Ensure Stable Supply of Radioligand Therapies in Japan
  May 26, 2025

• ORGANIZATION FPMAJ Sets Out on New Lobbying Push with Astellas’ Yasukawa as New Chief
  May 23, 2025

• ORGANIZATION Takeda’s Miyabashira Elected as New JPMA President
  May 23, 2025

• BUSINESS Japan Pharma Market Grows 1% to Record 11.4 Trillion Yen in FY2024: IQVIA
  May 23, 2025

• BUSINESS MSD Chief Decries Japan’s Unpredictable Policy Flip, Frets Future Investment
  May 22, 2025

• BUSINESS Sanofi Japan Seeing Improved Customer Satisfaction with AI-Powered Sales Support Tool
  May 21, 2025

• REGULATORY Japan Approves Moderna RSV Vaccine, GSK’s ADC, and More
  May 20, 2025

• ORGANIZATION PhRMA Raps Japan’s Drug Price Controls as Non-Tariff Trade Barriers, Urges US Govt Action
  May 19, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• …
• Next ›
• 最終 »